Marijuana Business Magazine September 2019

Marijuana Business Magazine | September 2019 8 4,000 Estimated number of registered medical marijuana patients in Thailand when the country began dispensing cannabis oil through 12 hospitals in August 2019. The Global Cannabis Marketplace L egal cannabis continues to blaze its path across the globe. Some form of legalized marijuana exists in dozens of nations, representing six of the world’s seven continents, with most of these countries endorsing medical cannabis use only. North America, South America and Europe host the greatest proportion of countries with legal cannabis, while Africa and Asia lag behind, and rules regarding mar- ijuana consumption on Antarctica remain murky. As legal cannabis markets develop around the world, vast differences have revealed themselves in terms of pricing—with price differentials stemming from differ- ences in the strictness of regulations, sourcing logistics and the number of the participants in each program. Source: GKV-Spitzenverband, Global Cannabis Partnership, Medical Cannabis in Europe: The Markets & Opportunities, Marijuana Business Daily, Reuters, Seedo Cannabis bythe Numbers | Maggie Cowee $83.8 million MJBizDaily estimate (74.4 million euros) for 2018 sales of medical cannabis flower in the EU. Number of marijuana businesses, agencies and affiliates that banded together to form the Global Cannabis Partnership with an eye toward creating international standards for safe and responsible production, distribution and consumption of legal cannabis. The 16 founding-member organizations are based either in Canada or the United States, with other member organizations headquartered in Australia, England and Israel. 4,165 Marijuana Business Daily estimate for kilograms of cannabis sold (9,182 pounds) in 2018 in the European Union. Roughly 68% of this total is estimated to have been sold in Germany, 16% in Italy and 13% in the Netherlands, with the balance sold across other EU nations. 45 Total cannabis sales (24.5 million euros) covered by health insurance in Germany from January 2019 to March 2019, including sales of unprocessed flower, preparations and finished pharmaceutical products. This figure doesn’t include sales via private prescriptions not covered by statutory insurance. $27.6 million